MedElevator
Войти в исследования Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026
Concussion in the Wild: Clinical Utility of Ambulatory Assessment of Symptoms and Everyday Exposures in Adolescents and Adults with Concussion.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Durfee Kori J, Elbin R J, Womble Melissa N, Jennings Sabrina, Dollar Christina M, Schatz Philip, Elbich Daniel B, Hakun Jonathan G
Аннотация
OBJECTIVE: To describe the degree of correspondence between ecological momentary assessment (EMA) symptom ratings and cognitive performance derived from the Mobile Neurocognitive Health Project (MNCH) and clinic-based standard-of-care assessments in adolescents and adults with concussion. Environmental exposures, avoidance behavior, and symptom reactivity data were documented, and the clinical utility of the MNCH protocol for predicting protracted recovery was examined.
METHOD: 89 patients (13-25 yrs) with concussion enrolled in the MNCH study on their smartphones within one week of injury. Participants completed four brief surveys per day for a 7-day period. The surveys included assessments of environmental exposures, avoidance of symptom-provoking environments, symptom ratings, ultra-brief performance-based cognitive assessments, and ratings of symptom reactivity to the surveys and cognitive assessments. The primary criteria used for determining the utility of EMA-based data were the degree of correspondence with in-clinic symptom ratings and cognitive performance, and the ability of EMA-based measures to predict risk for protracted recovery.
RESULTS: Symptom scores and cognitive performance outcomes obtained via EMA were significantly associated with in-clinic symptom ratings (PCSS) and computerized neurocognitive testing (ImPACT). Multiple logistic modeling results indicated that EMA total symptom scores were stronger predictors of protracted recovery than in-clinic symptom ratings. Additionally, ratings of avoidance behavior and reactivity to the EMA surveys and assessments were significantly associated with protracted recovery.
CONCLUSIONS: Valid estimates of concussion symptoms may be obtained via remote, unsupervised, high-frequency assessment. In addition to EMA-based symptom scores, avoidance behavior and symptom reactivity may yield prognostic information about risk for protracted recovery.
METHOD: 89 patients (13-25 yrs) with concussion enrolled in the MNCH study on their smartphones within one week of injury. Participants completed four brief surveys per day for a 7-day period. The surveys included assessments of environmental exposures, avoidance of symptom-provoking environments, symptom ratings, ultra-brief performance-based cognitive assessments, and ratings of symptom reactivity to the surveys and cognitive assessments. The primary criteria used for determining the utility of EMA-based data were the degree of correspondence with in-clinic symptom ratings and cognitive performance, and the ability of EMA-based measures to predict risk for protracted recovery.
RESULTS: Symptom scores and cognitive performance outcomes obtained via EMA were significantly associated with in-clinic symptom ratings (PCSS) and computerized neurocognitive testing (ImPACT). Multiple logistic modeling results indicated that EMA total symptom scores were stronger predictors of protracted recovery than in-clinic symptom ratings. Additionally, ratings of avoidance behavior and reactivity to the EMA surveys and assessments were significantly associated with protracted recovery.
CONCLUSIONS: Valid estimates of concussion symptoms may be obtained via remote, unsupervised, high-frequency assessment. In addition to EMA-based symptom scores, avoidance behavior and symptom reactivity may yield prognostic information about risk for protracted recovery.